Ethyl 5-hydroxydecanoate
| Code | Size | Price |
|---|
| TAR-T31703-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T31703-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
Ethyl 5-hydroxydecanoate is flavor and Fragrance Chemical Compounds.
CAS:
75587-06-3
Molecular Weight:
216.32
Purity:
0.98
SMILES:
O=C(OCC)CCCC(O)CCCCC
References
Selvarajan R, Sibanda T, Tekere M, Nyoni H, Meddows-Taylor S. Diversity Analysis and Bioresource Characterization of Halophilic Bacteria Isolated from a South African Saltpan. Molecules. 2017 Apr 20;22(4). pii: E657. doi: 10.3390/molecules22040657. PubMed PMID: 28425950; PubMed Central PMCID: PMC6154464.
Liang W, Chen M, Zheng D, Li J, Song M, Zhang W, Feng J, Lan J. The Opening of ATP-Sensitive K+ Channels Protects H9c2 Cardiac Cells Against the High Glucose-Induced Injury and Inflammation by Inhibiting the ROS-TLR4-Necroptosis Pathway. Cell Physiol Biochem. 2017;41(3):1020-1034. doi: 10.1159/000461391. Epub 2017 Feb 22. PubMed PMID: 28291959.
Jin C, Wu J, Watanabe M, Okada T, Iesaki T. Mitochondrial K+ channels are involved in ischemic postconditioning in rat hearts. J Physiol Sci. 2012 Jul;62(4):325-32. doi: 10.1007/s12576-012-0206-y. Epub 2012 Apr 19. PubMed PMID: 22528048.
Gross GJ, Hsu A, Gross ER, Falck JR, Nithipatikom K. Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction. J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):38-45. doi: 10.1177/1074248412437586. Epub 2012 Mar 9. PubMed PMID: 22407888; PubMed Central PMCID: PMC3449041.